Conditions

Results determined for 3-year study of liraglutide versus placebo diabetes risk reduction and weight management in individuals with prediabetes.

New research suggests HbA1c may be the most effective method to identify patients with undiagnosed prediabetes.

Results showed that the intervention will be cost effective.

Dr. W. Timothy Garvey talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about definition, treatment, and impact of obesity. Dr. W. Timothy Garvey MD, FACE  is a professor of Medicine and Chair of the Department of Nutrition Sciences at the University of …

Dr. W. Timothy Garvey talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about his message to medical professionals about the benefits of weight loss therapy in the treatment of type 2 diabetes. Dr. W. Timothy Garvey MD, FACE  is a professor of …

Dr. W. Timothy Garvey talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the differences in the various obesity guidelines. Dr. W. Timothy Garvey MD, FACE  is a professor of Medicine and Chair of the Department of Nutrition Sciences at the University …

In a talk with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas, Dr. W. Timothy Garvey explains a new medical diagnostic term for obesity. Dr. W. Timothy Garvey MD, FACE  is a professor of Medicine and Chair of the Department of Nutrition Sciences at the …

Dr. W. Timothy Garvey shares his thoughts about the impact of obesity on other medical conditions and complications with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas. Dr. W. Timothy Garvey MD, FACE  is a professor of Medicine and Chair of the Department of …

Diabetes in Control speaks with top endocrinologists and other medical professionals to bring you the latest in diabetes news and research. This week, we have a special interview with one of the presenters at the AACE 26th Annual Scientific & Clinical Congress in Austin, Texas, Dr. Scott Isaacs, who shares his knowledge about endocrinology, obesity, and medical weight loss.

Study focused on type 2 diabetes patients who initiate metformin.